Side effects not a major problem for new class of breast cancer drugs

A ground-breaking new class of oral drugs for treating breast cancer, known as cyclin-dependent kinase (CDK) inhibitors, are generally well-tolerated, with a manageable toxicity profile for most patients. This is the conclusion of a comprehensive review of toxicities and drug interactions related to this class of drugs.

9 Women Who Founded Multi-Million Dollar Companies on the Side

Sometimes a big idea begins as something small, coming when you least expect it and tacked on as a sort of hobby, playing second fiddle to your main event. Whether starting in the kitchen or dorm room, these ten brands grew in unexpected ways, surprising their founders as they became multi-million dollar companies. Here, ten women who created and built amazing companies on the side—proof that the best concepts can come when you’re pursuing something else.